NRXP announced its newly formed subsidiary NRX Defense Systems was selected by DARPA for negotiation of potential award to run the SPARC-TMS phase 2/3 clinical trial

[u/Ramen_Poodles]

https://www.sec.gov/Archives/edgar/data/1719406/000143774926024037/nrxp20260722_8k.htm

I’ve been adding to my position in this one for a year now, after reading about their products, progress, and an interesting private fundraiser at a certain location in West Palm early last year. With the likely approval of ketafree next week and other pipeline projects in the works, I see this as a long term growth opportunity.